Management
Committee

Marc LePage was appointed President and CEO of Génome Québec in December 2011. He brings to the organization a wealth of experience in the innovation sector and venture capital, in addition to a broad network of international contacts. One of his major mandates as President and CEO is to reach new agreements in a bid to diversify sources of funding.

He is an expert in international partnerships and, since 2009, served as Special Advisor, Climate Change and Energy for the Embassy of Canada in Washington, D.C. He previously worked as Consul General at the Canadian Consulate in San Francisco/Silicon Valley.

Marc LePage was also one of the pioneers behind the founding of Genome Canada in 2000. During his tenure as Executive Vice-President of Corporate Development, he made a significant contribution to the development of genomics in Canada.

From 1994 to 2000, he worked as Director of Business Development for the Medical Research Council, where he was in charge of building international partnerships with the pharmaceutical industry, venture capital and foundations.

Marc LePage is a member of the Board and the Governance Committee of the Quebec Network for Personalized Health Care. He also sits on the Board of Canada World Youth.

Marie-Kym Brisson has almost 25 years of experience in communication and public affairs in the life science, financial, political and cultural sectors. She has a long track record of achievements in environments influenced by various national sociopolitical agendas. Ms. Brisson holds a political science degree from Université de Montréal and a certificate in communication management from the École des hautes études commerciales, in partnership with the Publicité Club de Montréal.

Her current mandate is to develop and implement strategies to broaden the influence of Génome Québec and genomics in society. 

Claude Lamarre has 25 years of experience in accounting and management. A business administration graduate and chartered accountant, he has strong expertise in financial management, certification, information systems and project funding. At Génome Québec, Mr. Lamarre supervises a financial team of 6 employees. He is in charge of financial and budget information and of implementing good financial management practices in accordance with the principles of good governance.

Catalina López Correa is a graduate in General Medicine from Universidad Pontificia Bolivariana in Colombia. She also holds a Master’s in Human Genetics from the Pasteur Institute at Université Paris VII in France and a Ph.D. in Medical Biosciences from the Université catholique de Louvain in Belgium. During her career, she was the Principal Scientist for several companies, including Eli Lilly in the United States, deCode Genetics in Iceland, and Genomica in Great Britain. Ms. López Correa joined the Génome Québec team in July 2008 and, since March 2009, has served as its Vice President, Scientific Affairs. Two of her principal mandates involve promoting partnerships between academia and industry and facilitating networking between Québec researchers and those abroad.

Daniel Tessier worked for the National Research Council (NRC) Biotechnology Research Institute for 19 years. His work in genetics, protein engineering, new technology implementation, including the NRC’s pan-Canadian microarray platform and biosensors for the private sector, has resulted in over 40 published articles. Mr. Tessier holds a Master’s in Microbiology and Immunology from McGill University. He has worked as Senior Director, Operations and Business Development for the McGill University and Génome Québec Innovation Centre from 2005 to 2012. In 2012, he was appointed Vice President, Technology centres where he oversees a team of 65 employees.The technology centres supports major research initiatives in genomic and offers leading-edge services to the scientific community.